title: RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
authors.affiliation: Affiliations of authors: Centre of Public Health Sciences, University of Iceland, Reykjavik, Iceland (JET, LAM); Department of Epidemiology (MJS, LAM, ELG) and Department of Nutrition (MJS, ELG), Harvard School of Public Health, Boston, MA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (MJS, LAM, ELG).
authors.forename: Johanna E
authors.initials: JE
authors.lastname: Torfadottir
authors.forename: Meir J
authors.initials: MJ
authors.lastname: Stampfer
authors.forename: Lorelei A
authors.initials: LA
authors.lastname: Mucci
authors.forename: Edward L
authors.initials: EL
authors.lastname: Giovannucci
mesh_terms: D015525:Fatty Acids, Omega-3 / Q000009:adverse effects* / Q000097:blood*; D043371:Fatty Acids, Omega-6 / Q000097:blood*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology*
chemical_list: D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6